المؤلفون: Zsuzsanna Kahan, Daniela Grecea, Martin Smakal, Sergei Tjulandin, Igor Bondarenko, Luca Perjesi, Andras Illes, Karoly Horvat-Karajz, Ildiko Aradi

المصدر: BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)

مصطلحات موضوعية: Pegfilgrastim, Biosimilar, Chemotherapy-induced neutropenia, RGB-02, Clinical study, Breast Cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://link.springer.com/article/10.1186/s12885-019-5329-6; https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/b249d2754cfd438da7b013d32c4d7e50

المؤلفون: Andras Illes, Zsuzsanna Kahán, Ildiko Aradi, Dóra Sántha, Karoly Horvat-Karajz

المصدر: Future Oncology. 15:2083-2092

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Filgrastim, Neutrophils, medicine.medical_treatment, Neutropenia, Polyethylene Glycols, Leukocyte Count, 03 medical and health sciences, Pharmacoeconomics, 0302 clinical medicine, Chemotherapy induced, Neoplasms, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Economics, Pharmaceutical, Chemotherapy-Induced Febrile Neutropenia, Biosimilar Pharmaceuticals, Drug Approval, Chemotherapy, business.industry, Biosimilar, General Medicine, medicine.disease, United States, Europe, Treatment Outcome, 030104 developmental biology, Supportive psychotherapy, 030220 oncology & carcinogenesis, business, Pegfilgrastim, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4b5c3249579591dac468860e9414641
https://doi.org/10.2217/fon-2018-0891

المؤلفون: Igor Bondarenko, Zsuzsanna Kahán, Martin Smakal, Karoly Horvat-Karajz, Andras Illes, Daniela Grecea, Sergei Tjulandin, Luca Perjesi, Ildiko Aradi

المصدر: BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Docetaxel, Polyethylene Glycols, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Chemotherapy-induced neutropenia, RGB-02, Biosimilar, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, 030220 oncology & carcinogenesis, Female, Pegfilgrastim, medicine.drug, Research Article, Adult, medicine.medical_specialty, Neutropenia, Filgrastim, Breast Neoplasms, lcsh:RC254-282, Clinical study, 03 medical and health sciences, Breast cancer, Double-Blind Method, Internal medicine, Hematologic Agents, Breast Cancer, Genetics, medicine, Humans, Therapeutic equivalence, Biosimilar Pharmaceuticals, Neoplasm Staging, Chemotherapy, business.industry, medicine.disease, Regimen, 030104 developmental biology, Therapeutic Equivalency, Doxorubicin, business, Febrile neutropenia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6078b81798e3bd7c30b1b84933184cc
http://europepmc.org/articles/PMC6364429

المؤلفون: Kahan, Zsuzsanna, Grecea, Daniela, Smakal, Martin, Tjulandin, Sergei, Bondarenko, Igor, Perjesi, Luca, Andras Illes, Karoly Horvat-Karajz, Aradi, Ildiko

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6fb09d96310411ec148317b4f845e4